A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:1
作者
Fukushima, Daizo [1 ]
Imai, Shigeki [2 ]
Nishino, Noriyuki [1 ]
Hamada, Kohichi [3 ]
Horikawa, Yoshinori [1 ]
Shiwa, Yoshiki [1 ]
Nishida, Shinya [1 ]
Koyanagi, Ryota [3 ]
Wada, Hitoshi [4 ]
Sakuma, Hideo [5 ]
机构
[1] Southern Tohoku Gen Hosp, Dept Gastroenterol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[2] Southern Tohoku Res Inst Neurosci, Dept Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[3] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima 9601295, Japan
[4] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan
[5] Southern Tohoku Res Inst Neurosci, Dept Pathol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy; DRUG-ELUTING BEADS; ARTERIOPORTAL SHUNT; EFFICACY; SAFETY;
D O I
10.1007/s12328-020-01124-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:8
相关论文
共 50 条
  • [1] A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy
    Daizo Fukushima
    Shigeki Imai
    Noriyuki Nishino
    Kohichi Hamada
    Yoshinori Horikawa
    Yoshiki Shiwa
    Shinya Nishida
    Ryota Koyanagi
    Hitoshi Wada
    Hideo Sakuma
    Clinical Journal of Gastroenterology, 2020, 13 : 847 - 854
  • [2] Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
    Lv, Wei-Fu
    Liu, Kai-Cai
    Lu, Dong
    Zhou, Chun-Ze
    Cheng, De-Lei
    Xiao, Jing-Kun
    Zhang, Xing-Ming
    Zhang, Zheng-Feng
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4719 - 4726
  • [3] Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
    Patidar, Y.
    Basavaraj
    Mukund, Amar
    Sarin, Shiv K.
    INDIAN JOURNAL OF RADIOLOGY AND IMAGING, 2021, 31 (02) : 270 - 276
  • [4] Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study
    Yu, Jeong Il
    Park, Jae Won
    Park, Hee Chul
    Yoon, Sang Min
    Lim, Do Hoon
    Lee, Joon Hyeok
    Lee, Han Chu
    Kim, Seon Woo
    Kim, Jong Hoon
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (02) : 408 - 415
  • [5] Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization
    Liang, Hongyuan
    Cui, Peng
    Guo, Qiyong
    Mao, Xiaonan
    Wen, Feng
    Sun, Wei
    Shan, Ming
    Lu, Zaiming
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E331 - E341
  • [6] Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification
    Niu, Zhi-Jie
    Ma, Yi-Long
    Kang, Ping
    Ou, Sheng-Qiu
    Meng, Zhi-Bin
    Li, Zhi-Kun
    Qi, Feng
    Zhao, Chang
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2992 - 2997
  • [7] Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis
    Zhang, Yingqiang
    Fan, Wenzhe
    Wang, Yu
    Lu, Ligong
    Fu, Sirui
    Yang, Jianyong
    Huang, Yonghui
    Yao, Bwang
    Li, Jiaping
    ONCOLOGIST, 2015, 20 (12) : 1417 - 1424
  • [8] Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
    Cao, Yanyan
    Sun, Tao
    Guo, Xiaopeng
    Ouyang, Tao
    Kan, Xuefeng
    Chen, Lei
    Liang, Bin
    Wang, Mingfu
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
    Ling Li
    Niangmei Cheng
    Xinhui Huang
    Xiadi Weng
    Yubin Jiao
    Jingfeng Liu
    Wuhua Guo
    World Journal of Surgical Oncology, 20
  • [10] Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
    Li, Ling
    Cheng, Niangmei
    Huang, Xinhui
    Weng, Xiadi
    Jiao, Yubin
    Liu, Jingfeng
    Guo, Wuhua
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)